论文部分内容阅读
本文报道我省11所医院联合用赶黄草对急性黄疽型肝炎117例的临床疗效。结果临床显效率为93.2％,未见无效病例与毒性反应,对SGPT平均复常时间显著(P<0.05)优于对照组。本药对乙型肝炎及非乙型肝炎的治愈率分别为79.5％与76.9％,前者显著(P<0.05)优于对照药复方灵芝干糖浆的疗效(47.4％),而后者则与对照(71.0％)相近。据此,作者认为,本药是治疗急性黄疽型肝炎的安全有效单味中草药。
This article reports 11 hospitals in our province combined with cathay Pacific on the clinical efficacy of acute jaundice hepatitis in 117 cases. Results The clinical effective rate was 93.2%. No invalid cases and toxic reactions were observed. The mean duration of SGPT was significantly higher than that of the control group (P <0.05). The cure rates of Hepatitis B and non-Hepatitis B were 79.5% and 76.9% respectively, the former was significantly (P <0.05) superior to that of the control Ganoderma lucidum syrup (47.4%), while the latter was significantly lower than that of the control 71.0%). Accordingly, the author believes that the drug is safe and effective treatment of acute jaundice hepatitis single herb.